Aspirin for in vitro fertilisation

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 11, 2016, Pages

  Siristatidis, Charalampos S ^a   Basios, George ^a   Pergialiotis, Vasilios ^a   Vogiatzi, Paraskevi ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; ANTITHROMBOCYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADVERSE OUTCOME; CLINICAL EVALUATION; COCHRANE LIBRARY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DRUG EFFECT; DRUG EFFICACY; ECTOPIC PREGNANCY; EMBASE; HUMAN; IN VITRO FERTILIZATION; INFERTILITY THERAPY; LIVE BIRTH; LOW DRUG DOSE; MEDLINE; MULTIPLE PREGNANCY; OOCYTE RETRIEVAL; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PREGNANCY COMPLICATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; SPONTANEOUS ABORTION; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION; ULTRASOUND; VAGINA BLEEDING; ADULT; FEMALE; META ANALYSIS; PREGNANCY; PREGNANCY OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE INHIBITORS; FEMALE; FERTILIZATION IN VITRO; HUMANS; LIVE BIRTH; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84993928877     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004832.pub4     Document Type: Review

References (82)

1. Bordes A, Bied Dmaon VA, Hadj S, Nicollet B, Chomier M, Salle B. Does aspirin improve IVF results?. Human Reproduction 2003;18 Suppl 1:119. [3283643]
2. Check JH, Dietterich C, Lurie D, Nazari A, Chuong J. A matched study to determine whether low-dose aspirin without heparin improves pregnancy rates following frozen embryo transfer and/or affects endometrial sonographic parameters. Journal of Assisted Reproduction and Genetics 1998;15(10):579-82. [3283645]
3. Dirckx K, Cabri P, Merien A, Galajdova L, Gerris J, Dhont M, De Sutter P. Does low-dose aspirin improve pregnancy rate in IVF/ICSI? A randomized double-blind placebo controlled trial. Human Reproduction 2009;24(4):856-60. [3283647]
4. Duvan CI, Ozmen B, Satroglu H. Does addition of low-dose aspirin and/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study. Journal of Assisted Reproduction and Genetics 2006;23:15-21. [3283649]
5. Haapsamo M, Martikainen H, Tinkanen H, Heinonen S, Nuojua-Huttunen S, Rasanen J. Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study. Human Reproduction 2010;25(12):2972-7. [3283651]
6. Hung Lok I, Yip SK, Cheung LP, Leung PHY, Haines CJ. Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertility and Sterility 2004;81(3):556-61. [3283653]
7. Lambers MJ, Hoozemans DA, Schats R, Homburg R, Lambalk CB, Hompes PG. Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial. Fertility and Sterility 2009;92(3):923-9. [3283655]
8. Lentini GM, Falcone P, Guidetti R, Mencaglia L. Effects of low-dose aspirin on oocyte quality, fertilization rate, implantation and pregnancy rates in unselected patients undergoing IVF. Human Reproduction 2003;18 Suppl1:40. [3283657]
9. Moini A, Zafarani F, Haddadian S, Ahmadi J, Honar H, Riazi K. Effect of low-dose aspirin therapy on implantation rate in women undergoing in-vitro fertilization cycles. Saudi Medical Journal 2007;28(5):732-6. [3283659]
10. Pakkila M, Rasanen J, Heinonen S, Tinkanen H, Tuomivaara L, Makikallio K, et al. Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. Human Reproduction 2005;20:2211-4. [3283661]
11. Rubinstein M, Marazzi A, De Fried EP. Aspirin treatment increases ovarian and uterine blood flow and improves ovarian responsiveness, implantation, and pregnancy rates in assisted reproductive techniques: A prospective randomised double blind placebo controlled-study. Fertility and Sterility 1998;70 Suppl(3):119. [3283663]
12. Rubinstein M, Marazzi A, Polak de Fried E. Low dose aspirin treatment improves implantation and pregnancy rates in IVF patients: A prospective, randomized, double-blind study. Fertility and Sterility 1997;68 Suppl:49-50. [3283664]
13. Rubinstein M, Marazzi A, de Fried EP. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertility and Sterility 1999;71(5):825-9. [3283665]
14. de Fried EP, Rubinstein M. Aspirin and reproductive performance - reply of the authors. Fertility and Sterility 1999;72(4):754-5. [3283666]
15. Urman B, Mercan R, Aksoy S, Alatas C, Balaban B, Sertac A, Nuhoglu A. Low dose aspirin does not increase pregnancy and implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study. 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics, Sydney, Australia. 1999 May 9-14; Vol. Abstract 0-136:129. [3283668]
16. Urman B, Mercan R, Alatas C, Balaban B, Isiklar A, Nuhoglu A. Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: A prospective randomized study. Journal of Assisted Reproduction and Genetics 2000;17(10):586-590. [3283669]
17. Van Dooren IM, Schoot BC, Dargel E, Maas P. Low-dose aspirin demonstrates no positive effect on clinical results in the first in vitro fertilization (IVF) cycle. 60th Annual Meeting of the American Society for Reproductive Medicine. 2004; Vol. 82 Suppl 2:18. [3283671]
18. Akhtar MA, Eljabu H, Hopkisson J, Raine-Fenning N, Quenby S, Jayaprakasan K. Aspirin and heparin as adjuvants during IVF do not improve live birth rates in unexplained implantation failure. Reproductive BioMedicine Online 2013;26(6):586-94. [3283673]
19. Frattarelli JL, McWilliams GD, Hill MJ, Miller KA, Scott RT Jr. Low-dose aspirin use does not improve in vitro fertilization outcomes in poor responders. Fertility and Sterility 2008;89(5):1113-7. [3283675]
20. Geva E, Amit A, Lerner-Geva L, Lessing JB. Prevention of early pregnancy loss in autoantibody seropositive women. Lancet 1998;351(9095):34-5. [3283677]
21. Geva E, Amit A, Lerner-Geva L, Yaron Y, Daniel Y, Schwartz T, et al. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: A prospective study. American Journal of Reproductive Immunology 2000;43(1):36-40. [3283678]
22. Gizzo S, Capuzzo D, Zicchina C, Di Gangi S, Coronella ML, Andrisani A, et al. Could empirical low-dose-aspirin administration during IVFcycle affect both the oocytes and embryos quality via COX 1-2activity inhibition?. Journal of Assisted Reproduction and Genetics 2014;31(3):261-8. [3283680]
23. Grandone E, Villani M, Tiscia GL, Dentali F, Colaizzo D, Cappucci F, et al. Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience. PLoS One 2014;9(5):e97604. [3283682]
24. Guan Q, Ma HG, Wang YY, Zhang F. Effects of co-administration of growth hormone(GH) and aspirin to women during in vitro fertilization and embryo transfer (IVF-ET) cycles. Zhonghua Nan Ke Xue 2007;13(9):798-800. [3283684]
25. Haapsamo M, Martikainen H, Rasanen J. Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF/ICSI: a randomized, placebo-controlled, double-blind study. Human Reproduction 2009;24(4):861-6. [3283686]
26. Hanevik HI, Friberg M, Bergh A, Haraldsen C, Kahn JA. Do acetyl salicylic acid and terbutaline in combination increase the probability of a clinical pregnancy in patients undergoing IVF/ICSI?. Journal of Obstetrics and Gynaecology 2012;32(8):786-9. [3283688]
27. Hatasaka H. Immunologic factors in infertility. Clinical Obstetrics and Gynecology 2000;43(4):830-43. [3283690]
28. Hsieh YY, Tsai HD, Chang CC, Lo HY, Chen CL. Low-dose aspirin for infertile women with thin endometrium receiving intrauterine insemination: A prospective, randomized study. Journal of Assisted Reproduction and Genetics 2000;17(3):174-7. [3283692]
29. Hurst BS, Bhojwani JT, Marshburn PB, Papadakis MA, Loeb TA, Matthews ML. Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization. Journal of Experimental and Clinical Assisted Reproduction 2005;2:8-10. [3283694]
30. Kosar A, Kasapoglu B, Kalyoncu S, Turan H, Balcik OS, Gümüs EI. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study. Blood Coagulation & Fibrinolysis 2011;22(1):14-8. [3283696]
31. Kuo H-C, Hsu C-C, Wang S-T, Huang K-E. Aspirin improves uterine blood flow in the peri-implantation period. Journal of the Formosan Medical Association 1997;96(4):253-7. [3283698]
32. Kutteh WH, Yetman DL, Chantilis SJ, Crain J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Human Reproduction 1997;12(6):1171-5. [3283700]
33. Lambers MJ, Groeneveld E, Hoozemans DA, Schats R, Homburg R, Lambalk CB, et al. Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. Human Reproduction 2009;24(10):2447-50. [3283702]
34. Lee ES, Lee SH. The Efficacy of Low-dose Aspirin Therapy for Controlled Ovarian Hyperstimulation in IVF-ET. Korean Journal of Fertility and Sterility 2001;28(3):225-34. [4445158]
35. Madani T. The impact of low-dose aspirin on clinical reproductive outcomes in frozen-thawed embryo transfer cycles; A randomized, placebo-controlled double-blind study. International Journal of Fertility and Sterility 2014;8:109-110. Conference: 15th Congress on Reproductive Biomedicine and 9th Royan Nursing and Midwifery Seminar Tehran Iran. [4445160]
36. Matassa I, Morana T, Perino A, Pane A, Castelli A, Natale E, et al. Therapy with aspirin and ultra-sound guided embryo transfer in in-vitro fertilization. Giornale Italiano di Ostetricia e Ginecologia 2001;23(3):98-9. [3283704]
37. Mollo A, Strina I, Alviggi E, Varricchio MT, D'Uva M, Cadente C, et al. Effect of low-dose aspirin and prednisone administered after ovum pick-up on implantation and abortion rates in women with no auto-immune disorders undergoing ICSI: A prospective randomised trial. Giornale Italiano di Ostetricia e Ginecologia 2002;24(6):261-5. [3283706]
38. Mollo A, Varricchio MT, Strina I, Alviggi C, D'Uva M, Pisapia I, et al. Prednisone plus low-dose aspirin in women with no autoimmune conditions undergoing ICSI. Human Reproduction 2003;18 Suppl 1:115-6. [3283707]
39. Pergolini I, Gravotta E, Rampini MR, Marconi D, Alfano P, Gilio B, et al. Low molecular weight heparin versus cardioaspirin in embryo implantation in women undergoing ICSI without inherited trombophilia: A randomized pilot study. 29th Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE; 2013 Jul 7-10; London (UK). London (UK): Human Reproduction, Oxford University Press, 2013; Vol. 28:(pp i13). [3283709]
40. Evaluation of effect of oral Ritodrine on implantation rate in the in vitro fertilization (IVF)+ embryo transfer (ET) cycles in the infertile women: a randomized controlled trial. http://www.irct.ir/searchresult.php?id=6665&number=1. [3283711]
41. Revelli A, Dolfin E, Gennarelli G, Lantieri T, Massobrio M, Holte JG, et al. Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study. Fertility and Sterility 2008;90(5):1685-91. [3283713]
42. Rubinstein M, Marazzi A, Notrica J, Polak de Fried E. Oocyte donation programme: influence of age and aetiology and improvement of uterine blood flow velocity and pregnancy outcome after low-dose aspirin treatment. Human Reproduction 1999;14(1):180-1. [3283715]
43. Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, et al. High fercundity rates following in-vitro fertilization and embryo transfer in antiphospholipid seropositive women treated with heparin and aspirin. Human Reproduction 1994;9(12):2278-83. [3283717]
44. Sher G, Matzner W, Feinman M, Maassarani G, Zouves C, Chong P, et al. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. American Journal of Reproductive Immunology 1998;40(2):74-82. [3283719]
45. Stern C, Norris H, Chamley L, Baker HWG. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with IVF-implantation failure antiphospholipid or antinuclear antibodies. Human Reproduction 2001;16 Suppl 1:74. [3283721]
46. Stern C, Chamley L, Norris H, Hale L, Gordon Baker HW. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertility and Sterility 2003;80:376-83. [3283723]
47. Stoval DW, Van Voorhis BJ. Immunologic tests and treatments in patients with unexplained infertility, IVF-ET, and recurrent pregnancy loss. Clinical Obstetrics and Gynecology 1999;42(4):979-1000. [3283725]
48. Strehler E, Abt M, Jelinkova V, Paulus W, Reeka N, Sterzik K. Prednisone plus aspirin has no significant effect on pregnancy rates in IVF/ICSI cycles. Human Reproduction 2002;17 Suppl 1:P-339. [3283727]
49. Ubaldi F, Rienzi L, Ferrero S, Anniballo R, Iacobelli M, Cobellis L, et al. Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates. Human Reproduction 2002;17(6):1544-7. [3283729]
50. Vandana B, Singh M, Ibrahim R, Bansal A, Bose S. Art in older women. Climacteric. Conference: 14th World Congress on the Menopause Cancun Mexico. Conference Publication, Informa Healthcare 2014;17:pp 71. [3283747]
51. Várnagy A, Bódis J, Mánfai Z, Wilhelm F, Busznyák C, Koppán M. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome. Fertility and Sterility 2010;93(7):2281-4. [3283731]
52. Villani M, Dentali F, Colaizzo D, Tiscia GL, Vergura P, Petruccelli T, et al. Pregnancy-related venous thrombosis: comparison between spontaneous and ART conception in an Italian cohort. BMJ Open 2015;5(10):e008213. [4445162]
53. Wada I, Hsu CC, Williams G, Macnamee MC, Brinsden PR. The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Human Reproduction 1994;9(10):1954-7. [3283733]
54. Waldenström U, Hellberg D, Nilsson S. Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomised, prospective study. Fertility and Sterility 2004;81(6):1560-4. [3283735]
55. Wallace DJ, Weisman MH. The use of etanercept and other tumor necrosis factor-alpha blockers in infertility: It's time to get serious. Journal of Rheumatology 2003;30(9):1897-9. [3283737]
56. Weckstein LN, Jacobson A, Galen D, Hampton K, Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertility and Sterility 1997;68(5):927-30. [3283739]
57. Ying Y, Zhong YP, Zhou CQ, Xu YW, Wang Q, Li J, et al. A retrospective study on IVF outcome in patients with anticardiolipin antibody: effects of methylprednisolone plus low-dose aspirin adjuvant treatment. Journal of Reproductive Immunology 2012;94(2):196-201. [3283741]
58. Zhao Y, Du B, Jiang X, Ma M, Shi L, Zhang Q, et al. Effects of combining low-dose aspirin with a Chinese patent medicine on follicular blood flow and pregnancy outcome. Molecular Medicine Reports 2014;10(5):2372-6. [4445164]
59. Zhu Q, Wu L, Xu B, Hu MH, Tong XH, Ji JJ, et al. A retrospective study on IVF/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment. Reproductive Biology and Endocrinology 2013;11:98. [3283743]
60. Efficiency of low dose aspirin for prevention of ovarian hyper stimulation syndrome for in vitro fertilization cycles of the patient with polycystic ovarian syndrome. http://www.irct.ir/searchresult.php?id=6541&number=1. [3283745]
61. The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy. http://clinicaltrials.gov/show/NCT01633528. [3283749]
62. Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.. http://clinicaltrials.gov/show/NCT01924104. [3283751]
63. Bosetti C, Gallus S, La Vecchia C. Aspirin and cancer risk: an update to 2001. European Journal of Cancer Prevention 2002;11(6):535-42.
64. Dentali F, Ageno W, Rezoagli E, Rancan E, Squizzato A, Middeldorp S, et al. Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature. Journal of Thrombosis and Haemostasis 2012;10(10):2075-85.
65. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000;321:1183-7.
66. Fatemi HM, Popovic-Todorovic B. Implantation in assisted reproduction: a look at endometrial receptivity. Reproductive BioMedicine Online 2013;27(5):530-8.
67. Fishman P, Falah-Vaknine, Sredni B, Meroni PL, Rudniki C, Schoenfeld Y. Aspirin modulates interleukin-3 production: an additional explanation for the preventive effects of aspirin in antiphospholipid antibody syndrome. Journal of Rheumatology 1995;22(6):1086-90.
68. Flower R. What are all the things that aspirin does?. BMJ 2003;327(7415):572-3.
69. Gelbaya TA, Kyrgiou M, LI TC, Stern C, Nardo LG. Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis. Human Reproduction Update 2007;13(4):357-64.
70. Groeneveld E, Broeze KA, Lambers MJ, Haapsamo M, Dirckx K, Schoot BC, et al. Is aspirin effective in women undergoing in vitro fertilization (IVF)? Results from an individual patient data meta-analysis (IPD MA). Human Reproduction Update 2011;17(4):501-9.
71. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. A randomized comparison of streptokinase vs tissue plasminogen activator vs antistreplase and of aspirin plus heparin vs aspirin alone among 41299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-70.
72. Jouppilsa P, Kirkinen P, Koinla A, Ylikorkala O. Failure of exogenous prostacyclin to change placental and fetal blood flow in preeclampsia. American Journal of Obstetrics and Gynecology 1985;151:661-5.
73. Li DK, Liu L, Odouli R. Exposure to non-steroidal antiinflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. British Journal of Medicine 2003;327(7411):368.
74. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997;314(7076):253-7.
75. Royal College of Obstetricians and Gynaecologists. Scientific Advisory Committee Opinion Paper 5: Immunological testing and interventions for reproductive failure. RCOG Press 2003:1-8.
76. Ruopp M, Collins T, Whitcomb B, Schisterman E. Evidence of absence or absence of evidence? A re-analysis of the effects of low-dose aspirin in IVF. Fertility and Sterility 2008;90(1):71-6.
77. Siristatidis CS, Dodd SR, Drakeley AJ. Aspirin for in vitro fertilisation. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD004832.pub3]
78. Stewart WF, Kawas C, Corrada M, Metter EJ. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997;48(3):626-32.
79. Thun MJ, Henley SJ, Patrono C. Non-steroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic and clinical issues. Journal of the National Cancer Institute 2002;94(4):252-66.
80. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature: New Biology 1971;231(25):232-5.
81. Wallenburg HC, Rotmans N. Prevention of recurrent idiopathic fetal growth by low-dose aspirin and dipyridamole. American Journal of Obstetrics and Gynecology 1987;157(5):1230-5.
82. Yamaguchi M, Mori N. 6-Keto prostaglandin F1alpha, thromboxane B2 and 13-14 dihydro-15 keto prostaglandin F concentrations for normotensive and preeclamptic patients during pregnancy, delivery and the postpartum period. American Journal of Obstetrics and Gynecology 1985;151(1):121-3.